drugset / Trial / NCT04092309

Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation

NCT04092309

Unknown 90 enrolled University of Athens
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of the present study is to investigate the effect of ACE inhibitors and the sacubitril-valsartan complex in bone marrow transplant patients by assessing cardiovascular and endothelial parameters in order to search for a potent protective role.

Timeline

Start
2019-09-20
Primary completion
2020-09-01
Completion
2021-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Enalapril Other / unclassified
Subject Sacubitril/Valsartan Unknown